Date/Time
Date(s) - Wednesday, January 31, 2018
7:00 pm - 9:00 pm

Location
Biotech Without Borders

Categories No Categories

MouSensor, Inc. is an early stage biotech startup based on technology developed at Hunter College of The City University of New York by the company’s co-founders Drs. Paul Feinstein and Charlotte D’Hulst. MouSensor, Inc. generates super sniffer mice to build a live, human nose-on-a-chip with the bold vision to detect, discover and digitize every single smell on this planet; from the fragrances in a perfumer’s palette to the odors associated with diseases such as Parkinson’s. It is the company’s ultimate goal to establish the first-ever Digital Database of Smell, much like the RGB code for vision.

Dr. Charlotte D’Hulst was trained in bioengineering at the University of Leuven, Belgium and completed her doctoral studies at the University of Antwerp, Belgium in the Center of Medical Genetics working on Fragile X Syndrome. Research for which she received the Brain Research Young Investigators Award and the Fragile X Young Investigators Rising Star Award. As a post-doc in the Feinstein lab at Hunter College in New York City, she started working on the enigmatic sense of smell and pioneered the MouSensor technology that allows one to create customizable, transgenic super sniffer mice; research that earned her a nomination for the 2017 Regional Blavatnik Awards for Young Scientists. In 2016, she co-founded MouSensor, Inc. As CEO of this biotech startup, Charlotte is a strong supporter of Women in Bio and participated in several entrepreneurial programs in NYC to accelerate the development of the MouSensor technology into a successful business. To date, MouSensor, Inc. has raised over $450K in early-stage funding and has secured an important research agreement with a world-renowned chip technology innovator to continue successful development of their nose-on-a-chip.